The c-fos enhancer can be activated by many signaling pathways through distinct elements of the enhancer. The enhancer contains at its core the serum response element (SRE) that binds serum response factor (SRF). On the 5' side of the SRE is a site for p62 TCF which binds only when SRF is bound as well. p62
Introduction c-fos is an immediate early gene that can be activated by a variety of growth factors and mitogens through several dierent signaling pathways (Johansen and Prywes, 1995) . Activation by most of these pathways can be mediated by the c-fos enhancer located around 300 nucleotides 5' of the transcriptional initiation site (Treisman, 1992) . The central element of the c-fos enhancer is the Serum Response Element (SRE) which binds Serum Response Factor (SRF) (Johansen and Prywes, 1995) . The SRE is¯anked on the 5' side by a site which binds p62 TCF which can only bind when SRF is binding to the adjacent SRE. This is mediated by direct contacts of p62 TCF with SRF and its DNA binding site (Shaw et al., 1989; Treisman, 1994) . Besides the TCF-SRE site, the c-fos enhancer contains the Sis Inducible Element (SIE) which is responsive to PDGF (Wagner et al., 1990) . The SIE binds STAT family members (Fu and Zhang, 1993; Sadowski et al., 1993) . On the 3' side of the SRE there is an AP1-like site termed the c-fos AP1 site (FAP1). The function of the FAP1 site has been unclear since mutation of this site has not had a strong eect on induction of the promoter in transfection experiments (Fisch et al., 1987; Siegfried and Zi, 1989) . Notably, however, mutation of the site had a strong eect on expression of reporter genes introduced stably to transgenic mice (Robertson et al., 1995) .
The c-fos enhancer can be induced primarily by two types of signaling pathways. The ®rst involves phosphorylation of p62 TCF by MAPK family members while in the second rho can activate the SRE independently of p62 TCF . p62
TCF is encoded by any of three ets-related genes: elk-1, SAP1 or SAP2 (also known as Net1 and Erp1) (Treisman, 1994) . These factors have three related domains: the ets DNA binding motif, an SRF interaction domain, and a transcriptional activation domain that is regulated by MAPK phosphorylation (Treisman, 1996) . Each of the MAPK family members, Erk-1/2, JNK and p38 have been found to phosphorylate and activate Elk-1 (Gille et al., 1992; Marais et al., 1993; Whitmarsh et al., 1995 Whitmarsh et al., , 1997 . Rho activation of the SRE requires SRF but the mechanism is unknown (Hill et al., 1995) . Recently it was found that rho and LIM kinase regulation of actin treadmilling were critical to a pathway leading to SRE activation (Sotiropoulos et al., 1999) .
At 760 of the c-fos promoter there is a cAMP responsive element (CRE) that can also mediate induction of the promoter. The CRE can mediate cAMP and calcium induction in certain cell types but may also contribute to growth factor induction (Berkowitz et al., 1989; Fisch et al., 1989; Sassone-Corsi et al., 1988; Sheng et al., 1990) . The CRE is bound by CREB and the related transcription factor ATF1 (Ginty et al., 1994; Montminy, 1997; Sassone-Corsi et al., 1988) . Each is phosphorylated on a conserved serine (amino acid 133 in CREB and 63 in ATF1) that causes activation of the factors (Gonzalez and Montminy, 1989; Rehfuss et al., 1991) . This site is phosphorylated by cAMP-dependent protein kinase (PKA) and calcium-calmodulin dependent protein kinase (CaMK) which mediate cAMP and calcium induction, respectively (Liu et al., 1993; Matthews et al., 1994; Montminy, 1997) . Growth factorand stress-induced pathways can also activate CREB through phosphorylation of serine 133. These pathways act through the MAPKs Erk-1/2 and p38 (Iordanov et al., 1997; Tan et al., 1996; Xing et al., 1996 Xing et al., , 1998 , 1996, 1998) . In addition, both Erk-1/2 and p38 can activate the RSK-related kinase MSK1 which can then phosphorylate CREB (Deak et al., 1998; Pierrat et al., 1998) . The role of RSK2 in c-fos regulation was particularly highlighted in ®broblasts from Con-Lowry syndrome (CLS) patients that have a defect in the RSK2 gene. In these cells EGF induction of c-fos as well as EGF-induced phosphorylation of CREB were severely impaired (De Cesare et al., 1998) . In contrast, serum induction of c-fos and CREB phosphorylation were unaltered in CLS cells, suggesting that dierent signaling pathways are utilized.
In this study we have found that, along with the TCF-SRE site, the FAP1 site contributes to MAPK activation of c-fos reporter genes induced by the phorbol ester TPA or by activated Raf. In addition, the FAP1 site binds predominantly ATF1 and CREB from HeLa cell nuclear extracts. ATF1 and CREB phosphorylation are induced by TPA and dominant negative CREB and RSK2 constructs inhibited Erk activation of the reporter genes. These results suggest a model for Erk activation of the c-fos enhancer involving phosphorylation of TCF and ATF1/CREB by Erk and RSK family members, respectively.
Results
The c-fos AP1 site contributes to TPA and Raf-Erk activation
To check whether the c-fos AP1 (FAP1) site is functional in activating c-fos transcription, we constructed a series of luciferase reporter genes with the c-fos enhancer with or without the FAP1 site (Figure 1b ). These reporter genes were transfected into HeLa cells and assayed for serum or TPA induction. The FAP1 site had no signi®cant eect on serum induction but signi®cantly increased TPA induction (Figure 1a ; compare WT to DFAP1). The induction of the DFAP1 reporter was weak even though it contains a functional TCF site that was previously found to mediate TPA induction (Graham and Gilman, 1991) . To test whether the TCF and FAP1 sites acted together to mediate TPA induction, we mutated each site alone or in combination (Figure 1b) . We found that mutation of the TCF site (pm18) strongly reduced TPA induction although some residual induction was observed when the FAP1 site was present. Mutation of both sites completely abolished TPA induction (Figure 1a) . Since the basal level of expression was reduced by the DFAP1 and pm18 mutations, the fold induction by TPA was only modestly aected (as indicated by the numbers above the bars). However, no induction was observed when both the FAP1 and TCF sites were mutated. These results strongly suggest that TPA activates the c-fos enhancer through both the TCF and FAP1 sites.
We also tested the role of the SIE site which binds STAT factors (Fu and Zhang, 1993; Sadowski et al., 1993) . Mutation of this site increased TPA induction suggesting that there may be a negative element acting through this site (Figure 1a) .
TPA activation of c-fos has been found to be through activation of Erk MAP kinases and phosphorylation of p62 TCF (Treisman, 1994 (Treisman, , 1996 . We therefore tested whether activation of the Erk pathway can activate the c-fos enhancer through the TCF and FAP1 sites. Activated Raf (RafBXB) (Bruder et al., 1992) only very weakly activated the wt reporter gene but strongly activated when cotransfected with wt Erk2 (Figure 2a ). This activation required both the FAP1 and TCF sites since mutation of each strongly reduced expression ( Figure 2b ).
ATF1 and CREB bind the FAP1 site
Since the FAP1 site aected TPA and Erk activation of the c-fos enhancer, we investigated which factors bind this site. We used a gel mobility shift assay with HeLa cell nuclear extract and a probe, SREFAP1, spanning both the SRE and FAP1 sites ( Figure 3b ). Four bands were observed that were competed speci®cally by excess, unlabeled SREFAP1 oligonucleotide ( Figure  3a ). Band 1 is SRF since it was competed speci®cally by excess SRE oligonucleotide and since it was speci®cally blocked by anti-SRF sera (Figures 3a and  4a ). The three other bands that migrate faster than SRF, were competed by unlabeled FAP1 but not a (Figure 3a ). These results demonstrate that bands 2 ± 4 represent factors binding to the FAP1 site.
We also tested whether there was any change in binding to the SREFAP1 probe using nuclear extracts from TPA-induced HeLa cells, however there was no signi®cant change compared to uninduced extracts (data not shown).
Since the FAP1 site is similar to ATF sites as well as AP1 sites (Figure 3b ), we tested whether the factors binding to the FAP1 site were ATF or AP1 (c-jun or cfos) family members using speci®c sera. Antisera to ATF1 speci®cally blocked binding of bands 2 and 4, while there was no eect of antisera to ATF2, 3, 4 or 6 or to c-jun or c-fos (Figure 4a ). We previously found that these sera speci®cally blocked binding of their cognate factors (Clarke et al., 1998 , and data not shown). The anti-ATF1 sera was made against fulllength ATF1 and we have found that it does not crossreact with CREB (Clarke et al., 1998, and unpublished results) . To determine whether bands 2 or 4 contain CREB we used CREB-speci®c sera. This sera speci®cally blocked band 2 but not 3 or 4 ( Figure  4b ). These results are consistent with band 4 being a homodimer of ATF1 while band 2 is a heterodimer of ATF1 and CREB. This is similar to the case for two factors in HeLa nuclear extract binding to the c-jun ATF site (Clarke et al., 1998) . Since band 3 did not react with any of the sera, we could not identify it here.
Other factors binding the SRE that have been identi®ed include NFIL6/c/EBPb, YY1, SRE-ZBP and TFII-I-Phox1 (Attar and Gilman, 1992; Grueneberg et al., 1997; Gualberto et al., 1992; Kim et al., 1998; Metz and Zi, 1991) . None of these are likely to account for band 3 or the faint band migrating below band 4 in Figure 3a , since they would not be expected to be competed by the FAP1 oligonucleotide which does not span their binding sites (Attar and Gilman, 1992; Grueneberg et al., 1997; Gualberto et al., 1992; Kim et al., 1998; Metz and Zi, 1991) . E12 was also found to bind the SRE and may bind the FAP1 sequence since it contains its core CANNTG binding site (Metz and Zi, 1991) . All of the above factors, however, would be predicted to bind to the DFAP1 reporter gene (Figure 1 ) such that they are unlikely to (Mitchell and Tjian, 1989; Montminy, 1997) be responsible for the eect of FAP1 deletion on TPA induction. Further work will be required to determine whether E12 or other factors can account for bands detected in Figure 3a binding to the SRE-FAP1 region and whether they play a role in c-fos regulation.
Serum and TPA induced phosphorylation of ATF1 and CREB
Phosphorylation of CREB at serine 133 is well characterized as mediating activation of the factor in response to cAMP and growth factors such as EGF (De Cesare et al., 1999; Montminy, 1997) . ATF1 is highly homologous to CREB and contains the phosphorylation site at serine 63 corresponding to CREB serine 133. Since CREB phosphorylation can be induced by EGF and NGF through MAP kinase pathways (Iordanov et al., 1997; Xing et al., 1996 Xing et al., , 1998 , we tested whether TPA induces ATF1 and CREB phosphorylation in HeLa cells. We used antiphosphoCREB sera that is speci®c for CREB and ATF1 phosphorylated at serines 133 and 63, respectively. Immunoblotting with this sera showed a rapid increase in the level of phosphorylation of both ATF1 and CREB in cells treated with TPA (Figure 5a ). The level of ATF1 did not change as shown by immunoblotting with anti-ATF1 sera (Figure 5b ). Immunoblotting with anti-phosphoErk sera showed that this MAP kinase was activated with similar kinetics to ATF1 and CREB ( Figure 5c ). As a control, we immunoblotted with anti-Erk-2 sera and found no change in the level of Erk-2 (Figure 5d ). These results are consistent with results that Erk activation is upstream of ATF1 and CREB (Xing et al., 1996 (Xing et al., , 1998 . Erk-1/2 can activate the RSK related kinases (RSK1, 2 and 3 and MSK1) that can then directly phosphorylate CREB (Deak et al., 1998; Xing et al., 1996 Xing et al., , 1998 .
Dominant negative CREB and RSK2 inhibit c-fos enhancer activation
Since ATF1 and CREB are the predominant factors in HeLa nuclear extract that bind the FAP1 site and are inducibly phosphorylated on serine 63 or 133, respectively, we tested whether phosphorylation at this site was important for induction of the c-fos enhancer by the ERK pathway. We cotransfected ERK-2 and activated RAF (RafBxB) with a CREB expression vector with a serine to alanine mutation at serine 133 (CREBm1) such that it cannot be activated at this site. CREBm1 inhibited activation of the c-fos enhancer by about 60% suggesting that phosphorylation at serine 133 is important for induction ( Figure 6a ). As a control we found that CREBm1 had no signi®cant eect on Rho activation of an SRE reporter gene (Figure 6b ).
Since it has been reported that Erk-1/2 can activate RSK2 which can then phosphorylate and activate CREB on serine 133 (Xing et al., 1996 (Xing et al., , 1998 , we tested whether RSK2 is required for activation of the c-fos enhancer by the Erk pathway. We used a dominant negative RSK2 mutant (RSK2KR100) which has a point mutation in the kinase domain and has no kinase activity (Xing et al., 1996) . Raf plus ERK activation of the reporter gene was inhibited by RSK2KR100 by nearly 50% (Figure 6a) . As a control, RSK2KR100 did not inhibit RhoV14 activation of an SRE reporter gene (Figure 6b ). These results suggest that RSK2 at least partially mediates ERK activation of the enhancer although it is possible that the dominant negative RSK2 could be inhibiting by directly binding and inhibiting ERK-2 and/or by blocking the activation of other RSK family members.
Discussion
We have found that the FAP1 site contributes to TPA and ERK activation of the c-fos enhancer and that the predominant factors in HeLa cell nuclear extracts binding to the FAP1 site are ATF1 and CREB. In addition, we observed TPA-induced phosphorylation of ERK, ATF1 and CREB. Previous work has shown Figure 4 Binding of ATF1 and CREB to the c-fos FAP1 site. Antibodies (1 ml) to the indicated proteins were added to the gel mobility shift assay of HeLa nuclear extract and the SREFAP1 site as described in Figure 3 . The positions of migration of SRF and three factors binding to the FAP1 site are indicated to the left. PBS: phosphate buered saline; PI: pre-immune sera that TPA and ERK can activate c-fos through phosphorylation of p62 TCF (Treisman, 1994 (Treisman, , 1996 and that ERK can activate RSK family members to phosphorylate and activate CREB (Deak et al., 1998; Xing et al., 1996 Xing et al., , 1998 . Together these results suggest a model (Figure 7 ) in which TPA induction causes the activation of the RAF-MEK-ERK pathway and that ERK can then signal to the c-fos enhancer in two ways. First, it can activate by direct phosphorylation and activation of the transcriptional activation domain of p62 TCF (Elk-1, SAP1 or SAP2) (Treisman, 1994 (Treisman, , 1996 . Second, ERK can activate the FAP1 site through phosphorylation of RSK family kinases which phosphorylate and activate ATF1 or CREB on serines 63 or 133, respectively.
The FAP1 site in the c-fos enhancer was previously found to mediate cAMP induction of reporter constructs redundantly with other elements in the cfos promoter such as the CRE site at 760 (Berkowitz et al., 1989; Fisch et al., 1989) . However, the role of the FAP1 site in serum or growth factor induction has been less clear. Deletion of the FAP1 site from c-fos reporter constructs had no eect on serum, EGF or TPA induction (Fisch et al., 1987; Siegfried and Zi, 1989) . However, these reporter genes contained over 200 nucleotides of the c-fos promoter including the CRE site at 760. The eect of the FAP1 site observed here is likely because it was assayed without the 760 CRE which also binds ATF1 and CREB (Ginty et al., 1994; Sassone-Corsi et al., 1988) and because the eect is clearer in conjunction with mutation of the TCF site. The role of the FAP1 site has most dramatically been shown in transgenic mouse with fos-lacZ constructs (Robertson et al., 1995) . In these mice, mutation of the FAP1 site nearly abolished expression of the fos-lacZ reporter genes in tissues constitutively expressing c-fos. In addition, induction of the fos-lacZ reporter was severely impaired in brain and ®broblast cell cultures from the transgenic mice. This eect of mutation of the FAP1 site may re¯ect the requirement for ATF1 and/ or CREB to bind this site and respond to the signaling pathway proposed in Figure 7 .
We found three factors from HeLa cell nuclear extracts that speci®cally bound the FAP1 site. Using speci®c antisera, we can account for two of these factors as containing ATF1 and CREB, while the third factor remains unidenti®ed. ATF1 and CREB are highly related basic-leucine zipper factors that can be activated by phosphorylation at serines 63 and 133, respectively. They can be activated in response to increased cAMP levels due to their phosphorylation by (7) or dominant negatives CREBm1 or RSK2KR100 (3 mg each) were added as indicated. Luciferase activities were determined as in Figure 2 . (b) HeLa cells were transfected as in a except that activated RhoA (RhoV14) was added with the pm18DFAP1 reporter gene Figure 7 Model for TPA activation of the c-fos enhancer. See Discussion for details cAMP-dependent protein kinase (De Cesare et al., 1999; Montminy, 1997) . They can also be activated by phosphorylation at the same site by calcium calmodulin dependent protein kinase and RSK1, 2 and 3 as well as the RSK-related kinase MSK1 (Deak et al., 1998; Matthews et al., 1994; Pierrat et al., 1998; Xing et al., 1996 Xing et al., , 1998 . The RSK family can be phosphorylated and activated by ERK MAP kinases while MSK1 can be activated by either ERK or p38 (Deak et al., 1998; Pierrat et al., 1998; Xing et al., 1996 Xing et al., , 1998 . These kinases cause ATF1 and CREB to respond to a wide variety of signaling pathways.
The role of RSK2 in growth factor regulation of ATF1 and CREB is particularly notable. It was puri®ed as the main NGF-induced CREB-kinase in PC12 cells (Xing et al., 1996) . Mutations in the RSK2 gene and loss of RSK2 activity have also been associated with Con-Lowry syndrome (CLS) which is characterized by severe psychomotor retardation, facial and digital dymorphisms, and progressive skeletal deformations (Trivier et al., 1996; Young, 1988) . EGF-induced CREB phosphorylation was lost in ®broblasts from CLS patients while there was no change in cAMP, UV or serum induced CREB phosphorylation (De Cesare et al., 1998) . EGFinduction of c-fos expression was also greatly reduced in CLS cells suggesting that RSK2 is required for EGF induction of c-fos, possibly through phosphorylation of CREB and ATF1. Our results further suggest that RSK activation of CREB and ATF1 activates the c-fos enhancer through the FAP1 site adjacent to the SRE in addition to the CRE site located at 760. The role of RSK2 in ®broblasts is consistent with the inhibition of activation we observed with dominant negative RSK2 in HeLa cells. Further work will be required to de®nitively show that RSK2 is required for TPA activation of the c-fos promoter. It is also likely that other RSK family members will mediate activation of the c-fos enhancer in other cell types or in response to other inducers.
The c-fos enhancer can be activated by multiple signaling pathways. We have shown here that the RAF-MEK-ERK pathway can activate through the TCF and FAP1 sites. Other MAPK family members, JNK and p38, can also activate through the TCF site (Whitmarsh et al., 1995 (Whitmarsh et al., , 1997 . The JNK pathway does not cause CREB phosphorylation, however p38 can activate MAPKAP-kinase 2 which can phosphorylate CREB (Iordanov et al., 1997; Tan et al., 1996) . Therefore p38 may also activate the c-fos enhancer through the FAP1 site. Independently of TCF, serum and lysophosphatidic acid (LPA) can activate the SRE through signaling pathways involving RhoA, a small GTPase which can induce stress ®bers (Hill et al., 1995; Wang et al., 1998) . We found that the FAP1 site had no eect on activated RhoA-V14 induction of the c-fos enhancer suggesting that Rho does not act through this site (data not shown). The direct mechanism of Rho induction of the SRE is unclear, however it was recently found that Rho and LIM kinase control of actin treadmilling and the control of free actin concentrations in the cells was critical for Rho and LIM kinase activation of the SRE (Sotiropoulos et al., 1999) . In an additional pathway, increased calcium concentrations can also activate the SRE independently of the TCF site through a CaMK dependent pathway (Miranti et al., 1995) . Since CaMK can also activate CREB, it is possible that the FAP1 site may also mediate calcium induction of the c-fos enhancer along with the SRE.
Materials and methods

Immunoblotting and gel mobility shift assays
Cell lysates were prepared from serum or TPA induced HeLa cells by resuspending the cells in 0.2 ml of 36 sodium dodecyl sulfate (SDS) sample buer (6% SDS, 180 mM TrisHCl (pH 6.8), 30% glycerol, 0.003% bromophenol blue). The lysates were analysed by immunoblotting using a 1 : 1000 dilution of anti-phospho-CREB, anti-phospho-ERK (New England Biolabs), and anti-ATF1 (Clarke et al., 1998) . Horse radish peroxidase conjugated goat anti-rabbit IgG (Sigma) was used as a secondary antibody. Anti-CREB sera was a gift from Dr Michael Greenberg. Antisera to ATF-2, -3, -4 and cjun were gifts of Dr Tsonwin Hai. Anti-c-fos and anti-Erk-2 were from Santa Cruz Biotechnology. Anti-ATF6 was as described (Zhu et al., 1997) .
Nuclear extracts were made from HeLa cells and analysed by gel mobility shift assay for SREFAP1 site DNA-binding activity as described (Prywes and Roeder, 1986) . SREFAP1, a double stranded 43 bp oligonucleotide spanning the SRE and FAP1 sites (see sequence in Figure 3b ) was used as a probe.
Plasmids
Luciferase reporter genes: Plasmids pWTGL3, pWTDFAP-GL3, ppm18GL3, ppm18DFAPGL3, psieDFAPGL3 and psiepm18DFAPGL3 contain 7355 to 7285 of the murine c-fos promoter fused to 753 to +45 of the human c-fos promoter subcloned into the pGL3 luciferase vector (Promega) upstream of the ®re¯y luciferase gene. The mutations in these constructs are diagrammed in Figure 1b . The sequences, with the mutations underlined are: WT: GAGCTGTTCCCGTCAATCCCTCCCTCCTTTACACAG-G AT GTCCAT ATTA GGA CATCT GCGT CAGCAGGTT. DFAP: GAGCTGTTCCCGTCAATCCCTCCCTCCTTTA-CACAGG ATGTC CAT AT TAGGAC ATCT GCG. pm18: GAGCTGTTCCCGTCAATCCCTCCCTCCTTTACACAG-TAT GTC CAT AT TAG GAC ATC TGCGTC AGCAGGTT. sie: GAGCTGCTCACGTCAATCCCTCCCTCCTTTACA-CAGGATGTCCATATTAGGACATCTGCGTCAGCAGG-TT. Expression vectors: pRafBXB was used as an activated form of c-raf (Bruder et al., 1992) and RhoAV14 in pEXV was used as an activated form of RhoA (Qiu et al., 1995) . Rat Erk-2 in pCMV5 was a gift of Dr C Chandra Kumar. Dominant negative RSK2 (RSK2KR100) in pMT-HA and CREBm1 (serine 133 to alanine) in pcDNA3 with an RSV promoter were gifts from Dr Michael Greenberg.
Transfections and luciferase assays
HeLa cells were grown in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% newborn calf serum (NCS). Cells were transfected by the calcium phosphate coprecipitation method (Sambrook et al., 1989) . Each transfection cocktail for a 60 mm diameter plate contained 2 mg of luciferase reporter gene, 0.5 mg of pRL-SV40P (Chen and Prywes, 1999) as an internal control (containing the SV40 early promoter driving the Renilla luciferase gene), the indicated amounts of expression constructs and herring sperm DNA to give a total of 10 mg DNA. HeLa cells were transfected for 16 ± 20 h and then serum starved in DMEM and 0.2% NCS for 24 h. Cells were then induced with 100 ng/ml TPA or 20% NCS for 3 h. The transfected cells were lysed and assayed for ®re¯y and Renilla luciferase activity using the dual luciferase kit (Promega). The results were normalized to the Renilla luciferase activity of the internal control. Each experiment was repeated four or more times. The average and the standard error of the mean are shown.
